Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Health and Human Services Centers for Disease Control and Prevention [30 Day 11-10GP]
 The Centers for Disease Control and Prevention (CDC) publishes a list of information collection requests under review by the Office of Management and Budget (OMB) in compliance with the Paperwork Reduction Act (44 U.S.C. chapter 35). To request a copy of these requests, call the CDC Reports Clearance Officer at (404) 639-5960 or send an e-mail to 
                    *omb@cdc.gov.*
                     Send written comments to CDC Desk Officer, Office of Management and Budget, Washington, DC or by fax to (202) 395-5806. Written comments should be received within 30 days of this notice. Proposed Project *Clostridium difficile*
                     Infection (CDI) Surveillance—New—National Center for Emerging and Zoonotic Infectious Diseases, (NCEZID), Centers for Disease Control and Prevention, (CDC). Background and Brief Description Steady increases in the rate and severity of 
                    *Clostridium difficile*
                     infection (CDI) indicate a clear need to conduct longitudinal assessments of the impact of CDI in the United States. 
                    *C. difficile*
                     is an anaerobic, spore-forming, gram positive bacillus that produces two pathogenic toxins: A and B. CDI ranges in severity from mild diarrhea to fulminant colitis and death. Transmission of 
                    *C. difficile*
                     occurs primarily in healthcare facilities, where environmental contamination by 
                    *C. difficile*
                     spores and exposure to antimicrobial drugs are common. No longer limited to healthcare environments, community-associated CDI is the focus of increasing attention. Recently, several cases of serious CDI have been reported in what have been considered low-risk populations, including healthy persons living in the community and peri-partum women. The surveillance population will consist of persons residing in the catchment area of the participating Emerging Infections Program (EIP) sites. This surveillance poses no more than minimal risk to the study participants as there will be no interventions or modifications to the care study participants receive. EIP surveillance personnel will perform active case finding from laboratory reports of stool specimens testing positive for 
                    *C. difficile*
                     toxin and abstract data on cases using a standardized case report form. For a subset of cases (
                    *e.g.,*
                     community-associated 
                    *C. difficile*
                     cases) sites will administer a health interview. Remnant stool specimens from cases testing positive for 
                    *C. difficile*
                     toxin will be submitted to reference laboratories for culturing, and isolates will be sent to CDC for confirmation and molecular typing. Outcomes of this surveillance project will include the population-based incidence of community- and healthcare-associated CDI, and a description of the molecular characteristics of 
                    *C. difficile*
                     strains and the epidemiology of this infection among the population under surveillance. There is no cost to respondents to participate in this program. The total annualized burden for this data collection is 5,840 hours. Estimate of Annualized Burden Hours
Respondent
Number of 
                             respondents
Number of 
                             responses per  
                             respondent
Average burden per response 
                             (in hours)CDI Surveillance Case Report Form—Complete
10
437
1( print page 14022)CDI Surveillance Case Report Form—Partial
10
438
15/60CDI Surveillance Health Interview
10
50
45/60
 Dated: March 9, 2011. Carol Walker, Acting Reports Clearance Officer, Centers for Disease Control and Prevention.


[FR Doc. 2011-5919 Filed 3-14-11; 8:45 am] BILLING CODE 4163-18-P